News

Net profit of Torrent Pharmaceuticals rose 3.28% to Rs 566.00 crore in the quarter ended June 2026 as against Rs 548.00 crore during the previous quarter ended June 2025. Sales rose 54.57% to Rs 4835.00 crore in the quarter ended June 2026 as against Rs 3128.00 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales4835.003128.00 55 OPM %34.4232.99 - PBDT1347.00939.00 43 PBT754.00738.00 2 NP566.00548.00 3 Powered by Capital Market - Live News

The board of Torrent Pharmaceuticals has approved the appointment of Shanti Ekambaram (DIN: 00004889) as an Additional Independent Director of the Company for a term of 3 consecutive years effective from 30 July 2026, subject to approval of the shareholders of the Company.

Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 July 2026.

Torrent Pharmaceuticals announced that the 53th Annual General Meeting(AGM) of the company will be held on 23 June 2026.

Torrent Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 22 May 2026, inter alia, have recommended the final dividend of Rs 9 per equity Share (i.e. 180%) , subject to the approval of the shareholders.